Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.9600
-0.0128 (-1.32%)
At close: Aug 7, 2025, 4:00 PM
0.9501
-0.0099 (-1.03%)
Pre-market: Aug 8, 2025, 8:26 AM EDT

Kairos Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
1620---
Enterprise Value
1316---
Last Close Price
0.961.52---
PB Ratio
2.134.09---
P/TBV Ratio
2.334.29---
Debt / Equity Ratio
---0.31-0.50-0.34
Quick Ratio
4.491.280.040.270.04
Current Ratio
7.524.200.040.270.04
Return on Equity (ROE)
-149.74%-192.96%---
Return on Assets (ROA)
-46.61%-43.50%-107.07%-39.41%-
Return on Capital (ROIC)
-77.01%-87.69%---
Earnings Yield
-21.90%-13.33%---
Buyback Yield / Dilution
-21.50%-9.38%-1.42%-11.86%-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q